Glenmark to spin off originator drugs business
The US-based subsidiary will bring together existing research and development and manufacturing businesses in the US, India and Switzerland.
The US-based subsidiary will bring together existing research and development and manufacturing businesses in the US, India and Switzerland.
The company has been busy forming development and commercialization partnerships with other firms to develop antibodies in oncology and rheumatology.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.